DeVore Susan D. 4

What Happened
Susan D. DeVore, a director of Elevance Health, was granted 563 deferred stock units (DSUs) on May 13, 2026. The units were awarded at $0.00 per unit (total reported value $0) as part of the company's board compensation program; this is a compensation award rather than a market purchase or sale.

Key Details

• Transaction date: 2026-05-13; Form 4 filed: 2026-05-15 (appears timely).
• Award: 563 deferred stock units; price reported $0.00; aggregate cash value reported $0.
• Shares owned after transaction: not specified in this filing.
• Footnotes: F1—DSUs are accrued under the Elevance Health Board of Directors Compensation Program. F2—DSUs will be payable in company common stock upon the earlier of (a) five years from grant or (b) the date the reporting person ceases to be a director, unless a later date was elected under the plan.
• Transaction type/code: A = Award/Grant (compensation).

Context
Deferred stock units are a form of compensation that defer delivery of company shares until a future date or termination of board service; they do not represent an immediate purchase or sale and therefore are routine board compensation rather than a market sentiment signal.